Tokyo, Nov. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063493) titled 'A prospective observational study to evaluate the effects of imeglimin treatment on glycemic control and body composition in middle-aged and older patients with type 2 diabetes' on Nov. 2.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - Patients with type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effects of newly initiated oral imeglimin treatment on body composition and glucose metabolism in middle-aged and older patients.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 45
y...